Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of Washington's request for sensitive information.
This move was revealed after a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesman later clarified that the United States was seeking genetic material for research and commercial gain while was unwilling to guarantee the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more negotiations to reach a deal agreeable to both sides so the country's vital HIV programme can continue.
Wider Background
This rejection comes after a similar case in neighbouring Kenya, where a court suspended a similar deal with the US after legal challenges were raised about the safety of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.
As per reports, Sixteen African countries have so far signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would supply the basic resources for scientific discovery without any certainty that the end products would be available to our population if a new disease outbreak arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending systems already set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This mechanism is intended to guarantee that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent collaboration might be designed in a manner that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks should continue given that a large portion of the nation's HIV programmes depended on external financing.
"In cases where specific concerns exist, such as those relating to information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group commented.
This impasse highlights the continuing tensions between receiving vital foreign assistance and safeguarding national sovereignty in an ever more data-driven world.